Skye Bioscience Inc.

NASDAQ: SKYE · Real-Time Price · USD
3.53
0.26 (7.95%)
At close: Aug 15, 2025, 3:59 PM
3.51
-0.57%
After-hours: Aug 15, 2025, 07:36 PM EDT

Skye Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-26.57M -37.64M -19.48M -8.52M
Depreciation & Amortization
298.64K 124.25K 115K 34.13K
Stock-Based Compensation
8.32M 987.51K 629.03K 869.21K
Other Working Capital
-2.04M 231.98K -1.56M 128.31K
Other Non-Cash Items
-4.66M 23.05M 6.76M 497.01K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-2.63M -469.31K -761.9K 646.94K
Operating Cash Flow
-25.24M -13.95M -12.74M -6.47M
Capital Expenditures
-1.6M -12.55K -28.06K -90.87K
Cash Acquisitions
n/a 1.08M 5.31M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
1.36M 5.53M n/a n/a
Other Investing Acitivies
n/a n/a -66.46K n/a
Investing Cash Flow
-245.62K 6.6M 5.21M -90.87K
Debt Repayment
n/a 4.71M -210.76K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.62K -6.03K n/a 7.02M
Financial Cash Flow
83.56M 16.44M -208.79K 13.08M
Net Cash Flow
58.08M 9.09M -7.74M 6.51M
Free Cash Flow
-26.84M -13.96M -12.77M -6.57M